Solving Dermatology Study Challenges

Drive Smarter Decisions for Your Dermatology Study

Pharmaceutical companies conducting dermatology studies face competition for participants and sites, lengthy clinic visits, long trial durations, and subjectivity and variability in endpoints.

To be successful, dermatology clinical trials should be accessible to a wide range of potential participants. At the same time, reducing investigator and site burdens, start-up times, and ensuring consistent, high-quality assessments and data collection are key. Since many endpoints in dermatology clinical trials are based on visual evaluation of the skin, accurate, consistent, and objective assessments are crucial for these studies to succeed. Finally, investigators and the clinical study teams at all participating sites must be trained according to the same procedures and protocols to eliminate the possibility of significant variance in assessments from site to site or physician to physician within the same site.